News Conference News TCT 2020 Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up Michael O'Riordan October 23, 2020
Presentation TCT 2020 SCOPE I: One-year outcomes of a randomized trial comparing a self-expanding to a balloon-expandable transcatheter aortic valve Presenter: Thomas Walther October 17, 2020
News Conference News TCT 2020 Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2 Michael O'Riordan October 15, 2020
Presentation TCT 2020 Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial Presenter: Corrado Tamburino October 15, 2020
News Conference News TCT 2019 Predicting Final Valve Position After TAVR: Different Devices, Different Success Michael O'Riordan October 07, 2019
News Conference News TCT 2019 Portico Noninferior to Commercial TAVR Valves in IDE Study Caitlin E. Cox September 27, 2019
News Conference News TCT 2019 SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis Marcus A. Banks September 27, 2019
News Opinion Editor's Corner TCT 2019 TCT 2019 Day Two: Transcatheter Valves, New and Old Shelley Wood September 27, 2019